Document is current

Any future updates will be listed below

Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement

Crossref DOI link: https://doi.org/10.1007/s00277-015-2381-4

Published Online: 2015-04-23

Published Print: 2015-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark